Skip to content

MantraTM Surgical Robotic System, Model 3.0 - Interventional Clinical Study for 10 patients.

A prospective non-randomised pilot clinical study to evaluate the safety, feasibility, and efficacy of MantraTM Surgical Robotic System, Model 3.0 in the predetermined surgical procedures. - NO

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068556
Enrollment
10
Registered
2024-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: MantraTM Surgical Robotic System, Model 3.0: Robotic surgery used in conditions for: i. Cholecystectomy ii. Hysterectomy iii. Nephrectomy iv. Prostatectomy v. Oesophagus mobilizatio

Sponsors

Sudhir Srivastava Innovations Pvt. Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male or Female patients with age of eighteen (18) and above. Able to give written informed consent. Patients meeting the inclusion criteria for one of the following surgical procedures using MantraTM Surgical Robotic System, Model 3.0 for soft tissue surgeries: Cholecystectomy Hysterectomy Nephrectomy Prostatectomy Oesophagus mobilization Internal Mammary Artery takedown Cystectomy Lung Lobectomy Nephron Sparing Surgery Bilateral Pelvic Lymph Node Dissection Radical Cystoprostatectomy Partial Nephrectomy

Exclusion criteria

Exclusion criteria: Patients who have participated in another investigational clinical study within thirty (30) days before screening Inability to provide informed consent Uncontrolled Comorbidities such as hypertension, diabetes mellitus or any other co-morbidities that is considered as a high risk for the planned surgical procedure Patients who fall into New York Heart Association (NYHA) Class III or IV History of chronic alcohol or drug abuse. Chronic renal failure or on dialysis. Subjects with any other clinically significant unstable medical condition, life-threatening disease, or anything else in the opinion of the Investigator that would contra-indicate a surgical procedure.

Design outcomes

Primary

MeasureTime frame
System tasks could be performed safely on predefined procedures. System tasks required for the performance of predetermined procedures. System tasks required are feasible and could be carried out effectively. Device related adverse events.Timepoint: Procedure

Secondary

MeasureTime frame
Ease of the system by surgeons and operating room staff. Operative time – from incision to skin closure Blood loss during the surgery Length of hospital stay Return to the operating room within 24 hours of surgery. Rate of hospital readmission after discharge (Noted during the entire duration of the study) Adverse events during the follow-up period per protocol. Timepoint: Post Procedure till End of Study

Countries

India

Contacts

Public ContactPriyadarshini Arambam

Sudhir Srivastava Innovations Pvt. Ltd.

sudhir.srivastava@ssinnovations.org8912744440

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026